SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment
Zhichao He, Kakei Lam, Wenxia Zhao, Shan Yang, Yu Li, Jiayao Mo, Siyuan Gao, Dan Liang, Kaifeng Qiu, Min Huang, Junyan Wu
Topics & Concepts
Diabetic ketoacidosisMedicineEmpagliflozinCanagliflozinDapagliflozinOdds ratioDiabetes mellitusInternal medicineHypoglycemiaDiscontinuationHazard ratioAdverse Event Reporting SystemConfidence intervalAdverse effectEndocrinologyType 2 diabetesDiabetes Treatment and ManagementDiabetes and associated disordersPancreatic function and diabetes